| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |